Back to Search
Start Over
Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review
- Source :
- Journal of the International AIDS Society. December, 2019, Vol. 22 Issue 12, p1C, 6 p.
- Publication Year :
- 2019
-
Abstract
- Introduction: Knowledge of HIV status relies on accurate HIV testing, and is the first step towards access to HIV treatment and prevention programmes. Globally, HIV-status unawareness represents a significant challenge for achieving zero new HIV infections and deaths. In order to enhance knowledge of HIV status, the World Health Organisation (WHO) recommends a testing strategy that includes the use of HIV-specific antibody point-of-care tests (POCT). These POCTs do not detect acute HIV infection, the stage of disease when viral load is highest but HIV antibodies are undetectable. Complicating things further, in the presence of antiretroviral therapy (ART) for pre-exposure prophylaxis (PrEP) or post-exposure prophylaxis (PEP), other currently available testing technologies, such as viral load detection for diagnosis of acute HIV infection, may yield false-negative results. In this scoping review, we evaluate the evidence and discuss alternative HIV testing algorithms that may mitigate diagnostic dilemmas in the setting of increased utilization of ART for immediate treatment and prevention of HIV infection. Discussion: Missed acute HIV infection prevents people living with HIV (PLHIV) from accessing early treatment, increases likelihood of onward transmission, and allows for inappropriate initiation or continuation of PrEP, which may result in HIV drug resistance. While immediate ART is recommended for all PLHIV, studies have shown that starting ART in the setting of acute HIV infection may result in a delayed or complete absence of development of HIV-specific antibodies, posing a diagnostic challenge that is particularly pertinent to resource-limited, high HIV burden settings where HIV-antibody POCTs are standard of care. Similarly, ART used as PrEP or PEP may supress HIV RNA viralload, complicating current HIV testing algorithms in resource-wealthy settings where viral detection is included. As rollout of PrEP continues, HIV testing algorithms may need to be modified. Conclusions: With increasing use of PrEP and ART in acute infection we anticipate diagnostic challenges using currently available HIV testing strategies. Research and surveillance are needed to determine the most appropriate assays and optimal testing algorithms that are accurate, affordable and sustainable. Keywords: Acute HIV infection; pre-exposure prophylaxis; post-exposure prophylaxis; immediate antiretroviral therapy; HIV testing algorithms; indeterminate HIV test<br />1 | INTRODUCTION In the current era of immediate antiretroviral therapy (ART), and pre- or post-exposure prophylaxis, confidently diagnosing HIV is becoming increasingly complex. Cases of diagnostic uncertainty can be [...]
- Subjects :
- United States. Centers for Disease Control and Prevention -- Management
AIDS treatment -- Health aspects
Prophylaxis -- Health aspects
Algorithms -- Health aspects
Highly active antiretroviral therapy -- Health aspects
HIV infections -- Prevention -- Care and treatment -- Diagnosis -- Health aspects
HIV tests -- Usage -- Health aspects
Emtricitabine -- Usage -- Health aspects
HIV antibodies -- Health aspects
Drug resistance -- Prevention -- Care and treatment -- Diagnosis -- Health aspects
HIV -- Prevention -- Care and treatment -- Diagnosis -- Health aspects
Company business management
Algorithm
Health
Subjects
Details
- Language :
- English
- ISSN :
- 17582652
- Volume :
- 22
- Issue :
- 12
- Database :
- Gale General OneFile
- Journal :
- Journal of the International AIDS Society
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.618575089
- Full Text :
- https://doi.org/10.1002/jia2.25419